243 related articles for article (PubMed ID: 7910642)
1. Analysis in human immunodeficiency virus type 1 vectors of cis-acting sequences that affect gene transfer into human lymphocytes.
Parolin C; Dorfman T; Palú G; Göttlinger H; Sodroski J
J Virol; 1994 Jun; 68(6):3888-95. PubMed ID: 7910642
[TBL] [Abstract][Full Text] [Related]
2. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.
Kotsopoulou E; Kim VN; Kingsman AJ; Kingsman SM; Mitrophanous KA
J Virol; 2000 May; 74(10):4839-52. PubMed ID: 10775623
[TBL] [Abstract][Full Text] [Related]
3. Helper plasmids for production of HIV-1-derived vectors.
Fuller M; Anson DS
Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
[TBL] [Abstract][Full Text] [Related]
4. Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.
Richardson JH; Child LA; Lever AM
J Virol; 1993 Jul; 67(7):3997-4005. PubMed ID: 8510213
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIV-1 multiplication in a human CD4+ lymphocytic cell line expressing antisense and sense RNA molecules containing HIV-1 packaging signal and Rev response element(s).
Cohli H; Fan B; Joshi RL; Ramezani A; Li X; Joshi S
Antisense Res Dev; 1994; 4(1):19-26. PubMed ID: 7914762
[TBL] [Abstract][Full Text] [Related]
6. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
7. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
[TBL] [Abstract][Full Text] [Related]
8. A third-generation lentivirus vector with a conditional packaging system.
Dull T; Zufferey R; Kelly M; Mandel RJ; Nguyen M; Trono D; Naldini L
J Virol; 1998 Nov; 72(11):8463-71. PubMed ID: 9765382
[TBL] [Abstract][Full Text] [Related]
9. Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function.
Cui Y; Iwakuma T; Chang LJ
J Virol; 1999 Jul; 73(7):6171-6. PubMed ID: 10364378
[TBL] [Abstract][Full Text] [Related]
10. Rev-free HIV-1 gene delivery system for targeting Rev-RRE-Crm1 nucleocytoplasmic RNA transport pathway.
Srinivasakumar N
PLoS One; 2011; 6(12):e28462. PubMed ID: 22164294
[TBL] [Abstract][Full Text] [Related]
11. Mapping of the bovine immunodeficiency virus packaging signal and RRE and incorporation into a minimal gene transfer vector.
Molina RP; Matukonis M; Paszkiet B; Zhang J; Kaleko M; Luo T
Virology; 2002 Dec; 304(1):10-23. PubMed ID: 12490399
[TBL] [Abstract][Full Text] [Related]
12. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
Wagner R; Graf M; Bieler K; Wolf H; Grunwald T; Foley P; Uberla K
Hum Gene Ther; 2000 Nov; 11(17):2403-13. PubMed ID: 11096444
[TBL] [Abstract][Full Text] [Related]
13. cis-acting sequences involved in human immunodeficiency virus type 1 RNA packaging.
Kaye JF; Richardson JH; Lever AM
J Virol; 1995 Oct; 69(10):6588-92. PubMed ID: 7666564
[TBL] [Abstract][Full Text] [Related]
14. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
[TBL] [Abstract][Full Text] [Related]
15. The HIV-1 Rev/RRE system is required for HIV-1 5' UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles.
Cockrell AS; van Praag H; Santistevan N; Ma H; Kafri T
Retrovirology; 2011 Jun; 8():51. PubMed ID: 21702950
[TBL] [Abstract][Full Text] [Related]
16. A new-generation stable inducible packaging cell line for lentiviral vectors.
Farson D; Witt R; McGuinness R; Dull T; Kelly M; Song J; Radeke R; Bukovsky A; Consiglio A; Naldini L
Hum Gene Ther; 2001 May; 12(8):981-97. PubMed ID: 11387062
[TBL] [Abstract][Full Text] [Related]
17. A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery.
Srinivasakumar N; Schuening FG
J Virol; 1999 Nov; 73(11):9589-98. PubMed ID: 10516068
[TBL] [Abstract][Full Text] [Related]
18. Stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic sindbis virus vector.
Kong W; Tian C; Liu B; Yu XF
J Virol; 2002 Nov; 76(22):11434-9. PubMed ID: 12388704
[TBL] [Abstract][Full Text] [Related]
19. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner.
Rizvi TA; Schmidt RD; Lew KA
Virology; 1997 Sep; 236(1):118-29. PubMed ID: 9299624
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
